Reaction
Blood Fibrinogen Decreased reporting signals
As of the last recalculation, Blood Fibrinogen Decreased appears in 1,106 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 139.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pegaspargase | 84 | 139.6 | 140.6 |
| Alteplase | 78 | 105.1 | 105.7 |
| Vincristine Sulfate | 71 | 48.7 | 48.8 |
| Axicabtagene Ciloleucel | 24 | 46.8 | 46.9 |
| Cytarabine | 89 | 30.2 | 30.3 |
| Dexamethasone Sodium Phosphate | 15 | 28.2 | 28.2 |
| Mercaptopurine | 21 | 23.2 | 23.2 |
| Sodium Chloride Tablet | 75 | 20.5 | 20.5 |
| Sodium Chloride Tablets | 75 | 20.5 | 20.5 |
| Blinatumomab | 11 | 20.0 | 20.0 |
| Fludarabine Phosphate | 40 | 19.8 | 19.8 |
| Sodium Chloride | 75 | 19.1 | 19.1 |
| Brentuximab Vedotin | 10 | 18.5 | 18.5 |
| Calcium Gluconate | 11 | 17.3 | 17.4 |
| Meropenem | 28 | 16.8 | 16.8 |
| Dextrose | 11 | 15.9 | 15.9 |
| Dextrose Monohydrate | 11 | 15.6 | 15.6 |
| Linezolid | 23 | 14.8 | 14.8 |
| Canakinumab | 8 | 14.0 | 14.0 |
| Cefepime | 10 | 13.2 | 13.2 |
| Tranexamic Acid | 6 | 12.8 | 12.8 |
| Anakinra | 11 | 12.6 | 12.6 |
| Daptomycin | 6 | 12.3 | 12.3 |
| Cyclophosphamide Injection, Solution | 105 | 12.2 | 12.2 |
| Cyclophosphamide | 105 | 12.2 | 12.2 |
| Cyclophosphamide For Injection | 105 | 12.2 | 12.2 |
| Cefepime Hydrochloride | 10 | 11.8 | 11.8 |
| Ifosfamide | 13 | 11.5 | 11.5 |
| Mesna | 5 | 11.2 | 11.2 |
| Tocilizumab | 62 | 10.8 | 10.8 |
| Etoposide | 38 | 10.0 | 10.0 |
| Entecavir | 6 | 9.7 | 9.7 |
| Mesna Injection | 4 | 9.1 | 9.1 |
| Micafungin Sodium | 4 | 8.9 | 8.9 |
| Oseltamivir | 3 | 7.1 | 7.1 |
| Obinutuzumab | 6 | 6.9 | 6.9 |
| Selinexor | 3 | 6.5 | 6.5 |
| Avapritinib | 4 | 6.2 | 6.2 |
| Emicizumab | 3 | 4.6 | 4.6 |